Conversion surgery for hepatocellular carcinoma in the new era of targeted and immune checkpoint inhibitor therapies

被引：17
|
作者：
Zhao, Lei [1 ]
Zhao, Haitao [2 ]
机构：
[1] Shandong First Med Univ, Dept Hepatobiliary Surg, Shandong Canc Hosp, Jinan, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Liver Surg, Peking Union Med Coll Hosp, Beijing, Peoples R China
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2020年 / 9卷 / 06期
关键词：
SORAFENIB;
D O I：
10.21037/hbsn-20-693
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：809 / 811
页数：3
相关论文
共 50 条
  • [1] Combination of molecularly targeted therapies and immune checkpoint inhibitors in the new era of unresectable hepatocellular carcinoma treatment
    Liu, Ze-Long
    Liu, Jing-Hua
    Staiculescu, Daniel
    Chen, Jiang
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [2] Conversion surgery after preoperative therapy for advanced hepatocellular carcinoma in the era of molecular targeted therapy and immune checkpoint inhibitors
    Arita, Junichi
    Ichida, Akihiko
    Nagata, Rihito
    Mihara, Yuichiro
    Kawaguchi, Yoshikuni
    Ishizawa, Takeaki
    Akamatsu, Nobuhisa
    Kaneko, Junichi
    Hasegawa, Kiyoshi
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2022, 29 (07) : 732 - 740
  • [3] Current statuses of molecular targeted and immune checkpoint therapies in hepatocellular carcinoma
    Kong, Deqiang
    Liu, Chen
    Miao, Xiaolong
    Wang, Yao
    Ding, Xianfeng
    Gong, Weihua
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (05): : 1522 - 1533
  • [4] A closer look at immune checkpoint inhibitor-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies
    Guo, Christina
    Alexander, Marleise
    Dib, Youseph
    Lau, Peter
    Wheppler, Alison
    Au-Yeung, George
    Lee, Belinda
    Mooney, Don
    Joshi, Subodh
    Creati, Louise
    Sandhu, Shahneen
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 168 - 168
  • [5] Immune checkpoint inhibitor resistance in hepatocellular carcinoma
    Wang, Zhijie
    Wang, Yichuan
    Gao, Peng
    Ding, Jin
    CANCER LETTERS, 2023, 555
  • [6] Immune checkpoint inhibitor therapy for hepatocellular carcinoma
    Ramai, Daryl
    Shapiro, Alexandra
    Facciorusso, Antonio
    Bareggi, Claudia
    Gambini, Donatella
    Rijavec, Erika
    Tomasello, Gianluca
    Galassi, Barbara
    Ghidini, Michele
    ANNALS OF GASTROENTEROLOGY, 2022, 35 (06): : 568 - 576
  • [7] Hepatocellular Carcinoma: Review of Targeted and Immune Therapies
    da Motta Girardi D.
    Correa T.S.
    Crosara Teixeira M.
    Dos Santos Fernandes G.
    Journal of Gastrointestinal Cancer, 2018, 49 (3) : 227 - 236
  • [8] TACE plus immune checkpoint inhibitor-based systemic therapies for hepatocellular carcinoma
    Reiter, Florian P.
    Geier, Andreas
    LANCET, 2025, 405 (10474): : 174 - 176
  • [9] Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?
    Reparaz, David
    Aparicio, Belen
    Llopiz, Diana
    Hervas-Stubbs, Sandra
    Sarobe, Pablo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (04)
  • [10] Advances in targeted therapies for hepatocellular carcinoma in the genomic era
    Josep M. Llovet
    Augusto Villanueva
    Anja Lachenmayer
    Richard S. Finn
    Nature Reviews Clinical Oncology, 2015, 12 : 408 - 424
12345